First Uscan Sales in Japan

November 29th | 2016
Posted by: Takatsuna Kitagawa, Managing Director Japan

Uscan, our flagship product for advanced ultrasound in bladder care, was approved in Japan on August 1, 2016. We have been busy introducing this innovative device to the Japanese market, and I am pleased to announce that we received our first purchase from a practitioner clinic. On October 31, 2016, Ito Clinic located in Tosu (Saga Prefecture, Japan) received its Uscan unit. Ito Clinic specializes in urology, sexually transmitted diseases and dermatology, as well as provides treatment to patients with frequent urination and urinary incontinence. Ito Clinic’s decision to purchase Uscan was driven by the fact that its tablet design and general operation is easy for nurses to use, particularly when measuring residual urine. Furthermore, Ito Clinic liked how Uscan has abdominal ultrasound capabilities. Dr. Hiroki Ito, hospital director, said that he hopes this purchase will allow the hospital to begin house calls.

We are encouraged by the positive reception of Uscan in Japan and will share other updates in the months ahead.



A New Place to Call Home

November 21st | 2016
Posted by: Kevin Goodwin, CEO

Redmond, WA office

Adelaide, Australia office

There have been so many great things taking place this year for us here at Signostics, including the positive feedback we’re receiving from everyone who experiences Uscan, our advanced ultrasound for bladder care. As the end of 2016 nears, we’re looking forward to an even better 2017. One thing in particular that I am especially excited about is our new headquarters building that is currently under construction in Washington state. With the space minutes from downtown Redmond, we will be located near the headquarters of other local and innovative companies, such as Microsoft, Nintendo, AT&T and Big Fin. When deciding where we wanted to locate our new home, Redmond was a standout option.

The new office in Redmond offers us the opportunity to truly customize and design our space to meet our needs. The first floor will be home to production operations and a café/kitchen that will eventually provide catered meals for our employees. The second floor will have fifty private offices, shared work stations, three conference rooms and a multi-purpose room where trainings will be conducted. Once completed, our new space will be a total of 31,000 sq ft. I’m positive this will give us enough room to continue the rapid growth we’ve seen this year.

Similar to the setup we are creating in Redmond, we have an office in Adelaide, Australia, the birthplace of Signostics. Our Adelaide office has two floors with production on the first floor and office space on the second. Combining the two floors, we occupy 7,500 sq ft. The office location is especially unique because it’s located in the Tonsley Innovation District. Tonsley is Australia’s first innovation district with a mission to create an operating environment that assists South Australian businesses in their move into global markets. Other Tonsley tenants include Siemens, Flinders University and Zen Energy. Business IT magazine has suggested that Tonsley could become Australia’s own Silicon Valley. We take pride in being a part of this amazing community.

Our company is focused on building technology that enhances medical care and our new building in Redmond will accelerate our ability to deliver innovation for healthcare providers and patients. We look forward to sharing our progress on this new adventure in the coming months!



A Breakthrough in Bladder Care

July 22nd | 2016
Posted by: Kevin Goodwin, CEO

The first half of 2016 has been an exciting time for Signostics and I wanted to find a way to communicate and connect with the people that matter the most to us – you. Our customers, our patients, our community. So I’m launching this blog to enable Signostics to provide information and share perspectives on topics and issues relevant to the ultrasound industry. We are in a dynamic time with new ultrasound innovations and products being developed, and I’m proud that Signostics is playing a leading role in this evolving field.

In May Signostics received FDA clearance for Uscan™, a breakthrough device for advanced ultrasound in bladder care. Uscan provides real-time ultrasound imaging of the bladder, kidneys, pelvic floor, prostate, gallbladder, bladder stones and urological catheter emplacement, for quick and easy visual tracking and observation. This is important as it enables clinical care team members to acquire high-definition sonographic imaging that better informs treatment decisions, streamlines workflows and ultimately supports treatment of a wider range of patients.

I like to say Uscan doesn’t just scan, it sees. Because of our unique computer vision algorithms, we’re able to recognize the 3D contours of the bladder for far more accurate volume measurements than the industry standard, even on obese and hard-to-scan patients.

We now have colleagues in the field introducing Uscan across the country, and one story illustrates what Uscan can uniquely do. Recently at a presentation at a hospital, a nurse who claimed she had a “full bladder” volunteered to have her bladder volume measured using a few different bladder scanning devices. A competitor’s handheld device first read 183 mL and then 285 mL in two consecutive scans. Another device read 389 mL. We then scanned her two times with Uscan and received 449 and 451 mL measurements. Incredibly, the nurse volunteer voided 451 mL. Her fellow nurses said, “Now that is just too amazing” and “I love it,” proclaiming they had never had access to imaging bladder volume that was so accurate and easy to use.

Now that’s what I like to hear. These types of anecdotes drive us to do more to push ultrasound innovation. We have a wonderful new tool, and our technology can eliminate the guess work often employed in urologic care, and eventually beyond. Uscan has the potential to set a new standard in ultrasound imaging.

We recently introduced Uscan to physicians at the American Urological Associations’ 2016 Annual Meeting (AUA 2016) in San Diego. We had a live demonstration of the device at the exhibit booth and received extremely positive feedback from attendees, which reinforced that Uscan is a better device that is meeting a real need from health care professionals.

I can’t wait to see what else this year brings. Thanks for reading and please stay tuned for more posts about the future of ultrasound innovation.




The bladder volume measurement provided by the sales representative in this blog is just an example but does not reflect the actual accuracy of the device. Signostics cannot guarantee achieving this accuracy in every measurement but the device can measure Bladder volume with an accuracy of ±10% or ±10 mL, based on comparative measurements of a phantom of known volume. Please refer to device user manual.

© Signostics Ltd 2015